• FDA: Morning-after pill to move over the counter

    By Associated Press Posted: April 30, 2013 – 6:30 pm ET The government is moving the morning-after pill over the counter but only those 15 and older can buy it — an attempt to find middle ground just days before a court-imposed deadline to lift all age restrictions on the emergency contraceptive. Today, Plan B… Read more »

  • CMS proposes 1.1% payment bump for hospices

     Rich Daly Modern Healthcare Posted: April 29, 2013 – 7:15 pm ET Hospices would receive a $180 million boost from Medicare in the next fiscal year under a proposed rule issued Monday (PDF). The proposed rule would provide a 1.1% increase in fiscal 2014 payments to hospices, which treated more than 1.3 million Medicare beneficiaries in… Read more »

  • HRSA extends deadline for GPO compliance

    HRSA published Policy Release 2013-1 (PDF – 227 KB) on February 7, 2013 to clarify its policy regarding this 340B Program statutory prohibition.  HRSA initially allowed covered entities 60 days after the publication of the GPO policy release (until April 7, 2013) to make certain their drug replenishment practices comply with the GPO policy release. Based… Read more »

  • HRSA Policy Release – Audits

    HRSA OPA Policy Release Update The Office of Pharmacy Affairs (OPA) has revised Policy Release 2012-1 titled “Clarification of HRSA Audits of 340B Covered Entities.” The release was revised to remove the OMB Circular A-133 (A-133) audit component from OPA’s oversight strategies due to a number of concerns.  View Details 

  • HRSA 340B Registration opens

    Open registration for the 340B program begins on April 1 and runs through the 15th.  Eligible entities who want to participate in the 340B discounted drug pricing program must register with HRSA in order to access the program.  Activation of the registration takes place on July 1.  Additional open registrations for 2013 will take place… Read more »

  • United States: Health Reform Update: Focus on Prescription Drug Price Regulation

    PHS 340B Program Proposed Amendments The Senate Finance committee bill (S. 1679) and the House bill contain provisions which would significantly expand the PHS 340B discount program. Under that program, manufacturers may not charge “covered entities” for covered outpatient drugs more than a maximum discounted price that is equal to the difference between a drug’s… Read more »